Dr Esme Hill
/content/dam/genesiscare/headshots/uk-doctor-headshots/UK_Oncology_Headshot_GA_Dr-Esme-Hill.jpg

Dr Esme Hill

Dr Esme Hill
Esme
Hill
BSc, MBChB, MSc, MRCP, FRCR, DPhil Radiobiology, Clinical Oncologist

Languages spoken

English

Expert in

Upper GI

Overview

Centres

Windsor
Windsor
51.47755, -0.61809
/uk/our-centres/windsor

Dr Hill is the Clinical Lead for malignant spinal cord compression at the Royal Berkshire Hospital as well as an Educational Supervisor for Core Medical Trainees. She is a core member of the upper GI cancer multidisciplinary team at the Royal Berkshire and Wexham Park Hospitals and has strong working relationships with the Oxford oesophagogastric and hepato-biliary teams. She has a special clinical interest in upper GI, liver cancer and pancreatic cancer

 Dr Hill is co-investigator for the ADD-ASPIRIN trial and principal investigator (PI) for the SCOPE-2 trial. She has a significant portfolio of published work and has received several awards for her research. 

Career positions

Current position(s)
  • Consultant Oncologist and Clinical Lead, Royal Berkshire and Wexham Park Hospitals
  • Clinical Lead for malignant spinal cord compression at the Royal Berkshire Hospital
  • Educational Supervisor for Core Medical Trainees.
Year qualified
  • 2001

Expertise and interests

Interests
  • Upper GI, liver cancer and pancreatic cancer

 

Accomplishments

Awards received

  • Royal College of Radiologists Ross Prize for best proffered paper at the National Cancer Research Institute Conference in Liverpool (2013)
  • British Association of Cancer Research Travel Award for high quality abstract submission to the BACR conference (2013)